BLLN
BillionToOne, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$113.04
+2.34%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$113.86
From 52W high−24.62%
Volume219613.00
Market cap$5.33B
P/E (TTM)163.8x
P/S (TTM)13.4x
Div yield—
Key dataNov 4, 2026
Open
$113.86
From 52W high
−24.62%
Volume
219613.00
Market cap
$5.33B
ValuationView details →
P/E (Fwd)
132.6x
EV/EBITDA
98.1x
P/E (TTM)
163.8x
RSI (14)
56.3
MomentumView details →
1D Return
+2.34%
YTD Return
+36.19%
Similar companies
Latest newsMore news →
BillionToOne, Inc. announced that it plans to release financial results for the third quarter ended September 30, 2026, after market close on November 4, 2026, and hold a conference call that day.21d agoBillionToOne launched Northstar Origin, a new liquid biopsy add-on test for tissue-of-origin prediction, and expanded its Northstar Select panel from 84 to 102 genes.64d ago